Abstract
For psychostimulants, a marked individual variability in the dose-response relationship and large differences in plasma concentrations after similar doses are known. Therefore, optimizing the efficacy of these drugs is at present the most promising way to exploit their full pharmacological potential. Moreover, it seems important to examine oral fluid as less invasive biological matrix for its benefit in therapeutic drug monitoring for patients with hyperkinetic disorder. A high-performance liquid chromatography method for quantification of methylphenidate (MPH), dexamphetamine (DXA), and atomoxetine in serum and oral fluid has been developed and validated. The analytical procedure involves liquid-liquid extraction, derivatization with 4-(4,5-diphenyl-1H-imidazol-2-yl)benzoyl chloride as a label and chromatographic separation on a Phenomenex Gemini-NX C18 analytical column using gradient elution with water-acetonitrile. The derivatized analytes were detected at 330 nm (excitation wavelength) and 440 nm (emission wavelength). To examine the oral fluid/serum ratios, oral fluid samples were collected simultaneously to blood samples from patients with hyperkinetic disorder. The method allows quantification of all analytes in serum a...Continue Reading
References
Nov 1, 1992·Clinical Pharmacology and Therapeutics·N R SrinivasK K Midha
Nov 1, 1992·Clinical Pharmacokinetics·R K Drobitch, C K Svensson
Aug 11, 1998·Journal of Chromatography. B, Biomedical Sciences and Applications·O Al-DirbashiK Nakashima
Jan 11, 2000·Clinical Pharmacokinetics·H C KimkoD R Abernethy
Apr 13, 2000·Journal of Clinical Pharmacology·N B ModiS K Gupta
Sep 28, 2000·Journal of Mass Spectrometry : JMS·H J LeisW Windischhofer
Jun 14, 2003·Journal of Child and Adolescent Psychopharmacology·Jennifer W WitcherJoseph Biederman
Aug 1, 1956·Journal of Cellular Physiology·A S BURGEN
Apr 15, 2004·The Journal of Pharmacology and Experimental Therapeutics·Zejin SunWilliam F Bosron
May 25, 2005·Clinical Pharmacokinetics·John-Michael SauerJennifer W Witcher
Nov 22, 2005·Expert Opinion on Drug Delivery·Kennerly S PatrickJohn S Markowitz
Nov 23, 2006·Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences·Christine GreinerEkkehard Haen
May 5, 2007·Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences·Christine Greiner, Ekkehard Haen
Sep 7, 2007·Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences·Hao-Jie ZhuJohn S Markowitz
Jan 11, 2008·International Journal of Clinical Pharmacology and Therapeutics·D TuerckS Appel-Dingemanse
Apr 17, 2008·Der Nervenarzt·E HaenM Wittmann
Jul 19, 2008·Clinical Chemistry·François-Ludovic SauvagePierre Marquet
Nov 11, 2008·Clinical Drug Investigation·Suma M KrishnanJeffrey G Stark
Mar 18, 2010·Attention Deficit and Hyperactivity Disorders·Philip HazellRalf W Dittmann
Oct 1, 2011·Pharmacopsychiatry·E Haen
Oct 5, 2011·Pharmacopsychiatry·C HiemkeG Zernig
Dec 30, 2011·Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences·Ralf KoeberEkkehard Haen
Sep 26, 2012·Therapeutic Drug Monitoring·Ekkehard HaenDoris Melchner
Feb 22, 2013·Zeitschrift für Kinder- und Jugendpsychiatrie und Psychotherapie·Benedikt StegmannEkkehard Haen
May 9, 2015·Zeitschrift für Kinder- und Jugendpsychiatrie und Psychotherapie·Benedikt StegmannEkkehard Haen
Citations
Apr 15, 2020·Medicinal Research Reviews·Michele ProttiLaura Mercolini
May 11, 2018·Therapeutic Drug Monitoring·Katharina EbertHans-Willi Clement
Oct 23, 2019·BMC Chemistry·Haitham AlRabiahGamal Abdel-Hafiz Mostafa
May 12, 2018·Therapeutic Drug Monitoring·Joshua PreiskornMonica Biscaldi
Nov 6, 2020·Therapeutic Drug Monitoring·Christopher WohkittelManfred Gerlach
Nov 2, 2021·Drugs·Tanja R ZijpJob F M van Boven